Differences in Length of Stay and Pharmacologic Therapy for Infants Exposed to in Utero Opioids After Transition to the New Evaluation and Management Strategy, Eat Sleep Console
Document Type
Conference Proceeding - Restricted Access
Publication Date
5-9-2025
Abstract
With the increase in opioid use in the United States, there has been a concomitant increase in opioid use among pregnant women. Infants exposed to opioids in utero are at risk for developing Neonatal Abstinence Syndrome. These infants have a variety of symptoms, which can be managed with a combination of non-pharmacologic and pharmacologic interventions. Research in this area is focused on involving the family and reducing pharmacologic interventions with an approach called Eat Sleep Console (ESC), which involved families "rooming in" with the infant and assessing the infant's ability to eat, sleep, and be consoled. This approach has led to reduction in length of stay and use of opioid medication to manage symptoms. Our center transitioned to ESC in 2021. The goal of this study is to determine the impact of this change on length of stay and pharmacologic interventions in our NICU.
Recommended Citation
Prentice J, Hillard M, Stein M, Colombo L, Thompson B, Tucker J. Differences in length of stay and pharmacologic therapy for infants exposed to in utero opioids after transition to the new evaluation and management strategy, eat sleep console. Presented at: Research Day Corewell Health West; 2025 May 9; Grand Rapids, MI.
Comments
2025 Research Day Corewell Health West, Grand Rapids, MI, May 9, 2025. Abstract 1812